Publications
back to blog

A potent and highly selective irreversible HER2 inhibitor for treating HER2-driven cancers

Publications
This is some text inside of a div block.
April 18, 2023

Media Contacts

Related announcements

View All
View All
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
November 1, 2024

Previewing NeuralPLexer3: Towards fully AI-enabled Structure-Based Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more
October 29, 2024

Enchant whitepaper: Breaking the data wall between lab and clinic

Read more